Top 10 Value Stocks To Invest In Right Now


Top executives at United Parcel Service Inc. (NYSE: UPS) took home outrageously high compensation last year, even though the parcel carrier missed many of its performance targets, like revenue growth and total shareholder returns.

In fact, UPS said in its March filings with the U.S. Securities and Exchange Commission (SEC) its three-year performance missed targets for revenue growth, operating return on invested capital, and total shareholder returns.

Even worse, the world’s largest package delivery company also missed some of its financial targets for 2016. For example, UPS’s net income fell 29% last year after it struggled to handle the rising costs of e-commerce.


Yet UPS CEO David Abney earned a surprising 21% more in total compensation in 2016 than the prior year, according to the new SEC filings. Abney took in a whopping $13.7 million, including a salary of $1.1 million (a 6.3% increase), stock awards of $10.2 million (a 22% increase), and long-t erm awards valued at $860,000.

Top 10 Value Stocks To Invest In Right Now: Deckers Outdoor Corporation(DECK)

Advisors’ Opinion:

  • [By Matt Hogan]

    SKX is also highly attractive in a relative basis when compared to several of its publicly traded peers: Foot Locker, Inc. (NYSE: FL), Deckers Outdoor Group (NYSE: DECK), Wolverine World Wide, Inc. (NYSE: WWW) and Columbia Sportswear Company (NASDAQ: COLM). The company's forward EBITDA multiple of 6.9x is equal or below all of the comparable companies: FL (6.9x), DECK (7.6x), WWW (10.1x) and COLM (10.8x).

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

Top 10 Value Stocks To Invest In Right Now: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

Top 10 Value Stocks To Invest In Right Now: Identiv, Inc.(INVE)


Advisors’ Opinion:

  • [By Lisa Levin]

    The industries that are driving the market today are:

    Cement: This industry gained 3.4 percent by 2:30 pm. The top stock within the industry was Cemex SAB de CV (ADR) (NYSE: CX), which gained 4.7 percent. Cemex’s PEG ratio is 0.16. Computer Peripherals: This industry rose 2.6 percent by 2:30 pm ET. The top performer in this industry was Identiv Inc (NASDAQ: INVE), which gained 13.5 percent. Identiv shares have climbed 44.83 percent over the past 52 weeks, while the S&P 500 index has increased 8.61 percent in the same period. Internet Service Providers: The industry gained 2 percent by 2:30 pm. The top performer in this industry was TrueCar Inc (NASDAQ: TRUE) which gained 3.4 percent. TrueCar shares have jumped 60.90 percent over the past 52 weeks, while the S&P 500 index has increased 8.61 percent in the same period. Regional – Southwest Banks: This industry moved up 1.9 percent by 2:30 pm. The top performer in this industry was Veritex Holdings Inc (NASDAQ: VBTX), which rose 6.6 percent

Top 10 Value Stocks To Invest In Right Now: Territorial Bancorp Inc.(TBNK)


Advisors’ Opinion:

  • [By Lisa Levin]

    Territorial Bancorp (NASDAQ: TBNK) shares touched a new 52-week low of $21.31. Territorial Bancorp shares have dropped 9.43% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

Top 10 Value Stocks To Invest In Right Now: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Chris Lange]

    Ambarella, Inc. (NASDAQ: AMBA) reported fiscal fourth quarter financial results after markets closed on Tuesday. The company posted $0.92 in earnings per share (EPS) and $87.5 million in revenue, versus consensus estimates from Thomson Reuters that called for $0.74 in EPS and $86.07 million in revenue. The same period from last year had $0.64 in EPS on $67.97 million in revenue.

  • [By Peter Graham]

    Ambarella, Inc. (AMBA) has been all over the map over the last few years. It has defied gravity both to the up and to the downside, and although today’s suggested short of the stock is strictly technical, we do believe its current share price has once again gotten a little out of line when you compare it to the rest of the markets’ valuation metrics right now.

  • [By Peter Graham]

    Ambarella, Inc. (AMBA) has been all over the map over the last few years. It has defied gravity both to the up and to the downside, and although today’s suggested short of the stock is strictly technical, we do believe its current share price has once again gotten a little out of line when you compare it to the rest of the markets’ valuation metrics right now.

  • [By Peter Graham]

    We had GoPro Inc as a Elite Opportunity Pro (EOP)portfolio pick when it was still outperformingplus we havesuggested short-term short positions in thestock. We also had positions in semiconductor and high-definition video solutions stockAmbarella Inc (NASDAQ: AMBA)- a key GoPro Inc supplier.

Top 10 Value Stocks To Invest In Right Now: PacWest Bancorp(PACW)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Value Stocks To Invest In Right Now: ProShares Ultra Nasdaq Biotechnology(BIB)


Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Elite Opportunity Pronewsletter suggested theProShares Ultra Nasdaq Biotechnology ETF (NASDAQ: BIB) as a way to play long term biotech bullishness with a short term caveat:

Top 10 Value Stocks To Invest In Right Now: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Finisar Corporation (NASDAQ: FNSR) shares dropped 21 percent to $27.46 after the company reported weaker-than-expected results for its third quarter and issued disappointing forecast for the current quarter.

  • [By Anders Bylund]

    Shares of Finisar (NASDAQ:FNSR) rose 13.2% in February 2017, according to data from S&P Global Market Intelligence.

    So what

    The bulk of Finisar’s February surge started when chief rival Lumentum (NASDAQ:LITE) delivered a strong earnings surprise, followed by several rosy analyst reviews. Lumentum’s solid results led investors to optimistic conclusions about the many target markets these two companies have in common, and Finisar’s gains nearly matched Lumentum’s post-earnings surge.

  • [By Evan Niu, CFA]

    Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Finisar Corporation (NASDAQ: FNSR) reported in-line earnings for its fourth quarter, but issued a weak forecast for the current quarter. Finisar shares jumped 7.76 percent to $27.63 in the after-hours trading session. Shares of Booz Allen Hamilton Holding Corporation (NYSE: BAH) dropped over 13 percent in after-hours trading as the company reported a DoJ civil and criminal investigation regarding cost accounting and cost charging practices. Booz Allen shares dipped 13.30 percent to $34.10 in the after-hours trading session. Bob Evans Farms Inc (NASDAQ: BOBE) shares declined over 4 percent Thursday after the company reported results for its fourth quarter. The company posted better-than-expected Q4 earnings, while sales missed estimates. Bob Evans shares dropped 4.26 percent to close at $68.99 on Thursday.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Value Stocks To Invest In Right Now: Lennox International, Inc.(LII)

Advisors’ Opinion:

  • [By Greg Williamson]

    Watsco’s current P/E of 24.5 is in the same ballpark as its competitor Lennox International (NYSE: LII  ) (NYSE: LII  ) (NYSE: LII  ) , whose P/E is 23.8. Lennox is a manufacturer of HVAC equipment and components, and will also benefit from HVAC industry tailwinds.

Top 10 Value Stocks To Invest In Right Now: Novo Nordisk A/S(NVO)


Advisors’ Opinion:

  • [By Paul Ausick]

    Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.

  • [By Brian Orelli]

    Global Blood Therapeutics (NASDAQ:GBT) is up 20% at 3:42 p.m. EST after Reuters reported that Novo Nordisk (NYSE:NVO) has approached the biotech about a potential acquisition.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

Leave a Reply

Your email address will not be published. Required fields are marked *